Increased AMPK activity has been observed in the brain of patients with Alzheimer’s disease, and several studies have reported that Aβ42 oligomers can activate AMPK by a CaMKK2-dependent mechanism [56–58]. This evidence concerns the gene CAMKK2 and Alzheimer disease.